Skip to main content

Research

Multi-institutional study of Wilms tumor facilitates enrollment, optimizes treatment

Feb. 27, 2024—Vanderbilt reserch finds that enrollment and outcomes were similar across racial and ethnic groups for children participating in therapeutic trials for Wilms tumor — the most common pediatric kidney cancer worldwide

Read more


Large, diverse genetic study of glaucoma implicates vascular and cancer-related genes

Feb. 21, 2024—An international genetic study using multiancestry biobanks has identified novel genetic locations associated with primary open-angle glaucoma, the most common type of glaucoma and the leading cause of irreversible blindness globally.

Read more


VUMC part of major step to achieving precision medicine

Feb. 19, 2024—An analysis of genomic data from nearly 250,000 participants in the National Institutes of Health’s All of Us Research Program has identified more than 275 million previously unreported genetic variations, nearly 4 million of which have potential health consequences.

Read more


VISTA grant to fund hospital-based research training in heart, lung, blood, sleep disorders

Feb. 12, 2024—Vanderbilt University Medical Center has received a federal grant to establish a first-of-its-kind training program in patient-oriented and health systems research focused on acute heart, lung, blood and sleep disorders in the hospital setting.

Read more


Vanderbilt nanodrug may be a paradigm shift for cancer

Feb. 7, 2024—A multidisciplinary research team at Vanderbilt University and Vanderbilt University Medical Center has discovered a new way to kill a tumor by disrupting its acidic “microenvironment” without harming normal tissue.

Read more


VUMC study finds molecular switch key to repair of kidney damage

Feb. 7, 2024—Researchers at Vanderbilt University Medical Center have identified Rac1, a molecular switch that regulates the actin cytoskeleton of epithelial cells in the collecting ducts, as a driver of post-obstructive kidney repair.

Read more


A biomarker for early Type 2 diabetes

Feb. 1, 2024—Genetic analyses suggest that branched chain amino acids may be a sensitive biomarker of early or subclinical Type 2 diabetes and could be used to identify risk and implement preventive measures.

Read more


Fatty acids rewire energy supply chain in stomach cancer development

Jan. 31, 2024—A study by Vanderbilt researchers has revealed how metabolic changes spurred by fatty acids contribute to the transformation of cells into abnormal versions of themselves that are the precursors to stomach cancer.

Read more


3D brain mapping opens a window to the aging brain

Jan. 30, 2024—By mapping brain activity in three dimensions, researchers at Vanderbilt University Medical Center have achieved a more detailed picture of how the brain changes with age.

Read more


Expanded space boosts cutting-edge research in infectious diseases and immunology

Jan. 29, 2024—The Vanderbilt Institute for Infection, Immunology and Inflammation recently debuted state-of-the-art new facilities in Medical Center.

Read more


Harvard immunologist Springer next up in Discovery Lecture Series

Jan. 29, 2024—Harvard's Timothy Springer, PhD, a world leader in structural biology and immunology, will deliver the next Discovery Lecture at Vanderbilt on Thursday, Feb. 8.

Read more


Nominations sought for the 2024 Vanderbilt Prize in Biomedical Science

Jan. 29, 2024—Nominations for the 2024 Vanderbilt Prize in Biomedical Science are now being accepted. The nomination deadline is Feb. 29.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more